drugset / Trial / NCT07683949
Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine
Phase 1/2
Enrolling by invitation
93 enrolled
Seoul National University Bundang Hospital
Seoul National University Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
A New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy
Timeline
- Start
- 2026-06-15
- Primary completion
- 2029-10-31
- Completion
- 2029-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Lenvatinib | Small molecule | — | — |